Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk

Ocugen’s stock is framed as having upside from a packed 2026 catalyst calendar, but the article highlights limited cash runway and dilution risk as the main constraints. The outlook is described as finely balanced because the company remains pre-commercial, making funding execution as important as pipeline progress.

Analysis

Ocugen’s stock is framed as having upside from a packed 2026 catalyst calendar, but the article highlights limited cash runway and dilution risk as the main constraints. The outlook is described as finely balanced because the company remains pre-commercial, making funding execution as important as pipeline progress.